Dr. Amit Dutt Dwary

Dr. Amit Dutt Dwary

Consultant 

23 Years of Experience

Medical Oncologist

MBBS, MD, DM

Reg. No.:4201, Madhya Pradesh Medical Council

Apollo Gleneagles Hospital, Kolkata

Bengali, English, Hindi

Consultation Fee ₹ 500

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Amit Dutt Dwary

Expert Help When You Need It – Plan in 60 Minutes

About Dr. Amit Dutt Dwary

  • Dr. Amit Dutt Dwary is an esteemed Medical Oncologist with 23+ years of extensive practice in the field.
  • He completed his MBBS and MD at Mahatma Gandhi Memorial Medical College, Indore, in 2001 and 2004. 
  • Later, he specialized in cancer treatment by completing DM in Medical Oncology from the All India Institute Of Medical Science, New Delhi.
  • He is widely recognized for his proficiency in managing a wide spectrum of oncology disorders, such as Lung Cancer, Breast Cancer, Head and Neck Cancer, Gynecological Malignancies, and GI Tract Cancers.
  • Dr. Amit specializes in conditions such as Actinic Keratosis, Cholangiocarcinoma, Hairy Cell Leukemia, Acute Lymphoblastic Leukemia, Renal Cell Carcinoma, Langerhans Cell Histiocytosis, and Malignant Melanoma.
  • He was awarded a Gold Medal in Pharmacology by the Devi Ahilya Vishwavidyalaya, Indore, and for the best postgraduate student in AIIMS in oncology.
  • He has conducted various medical conferences and published research papers on Nivolumab and ROS-1 Crizotinib, among others, in reputed journals.

Confirm Your Consultation With Dr. Amit Dutt Dwary

Expert Help When You Need It – Plan in 60 Minutes

Education

  • MBBS - MGMMC, Indore, 2001
  • MD - MY Hospital and MGMMC, Indore, 2004
  • DM - Oncology - AIIMS (New Delhi), 2008

OPD Schedule Of Dr. Amit Dutt Dwary

Book Appointment

Past Experience

  • Consultant, Medical Oncology at Apollo Cancer Centre, Kolkata
  • Consultant – AMRI, Kolkata
  • Consultant – Tata Medical Centre, Kolkata
  • Role Of Low Dose Laser Treatment In Tubercular Lymphadenopathy, Sinuses And Abscess.
  • Comparison Of Gem-Ox, FUFA And BSC In Unresectable Gall Bladder Carcinoma.
  • A Pilot Study To Compare Expression Of P53,K-Ras And HER2/Neu In Normal And Gall Bladder Epithelium
  • A Randomized Control Trial Comparing Best Supportive Care, 5-FU Plus Folinic Acid And Gemcitabine Plus Oxaliplatin In Management Of Unresectable Gallbladder Cancer.
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology
  • ICON